US Stock MarketDetailed Quotes
ATHE Alterity Therapeutics
- 2.3300
- +0.2000+9.39%
Close Apr 24 16:00 ET
- 2.2900
- -0.0400-1.72%
Post 19:16 ET
20.34MMarket Cap-1195P/E (TTM)
2.5000High2.1406Low173.94KVolume2.1406Open2.1300Pre Close410.41KTurnover2.20%Turnover RatioLossP/E (Static)8.73MShares5.410052wk High1.78P/B18.45MFloat Cap1.550052wk Low--Dividend TTM7.92MShs Float51.5000Historical High--Div YieldTTM16.87%Amplitude1.5500Historical Low2.3590Avg Price1Lot Size
About Alterity Therapeutics Company
Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
Company Profile
SymbolATHE
Company NameAlterity Therapeutics
Listing DateSep 5, 2002
Founded1997
CEODr. David A. Stamler,M.D.
MarketNASDAQ
Employees11
Securities TypeDR
ADS Ratio1.0 : 600.0
Fiscal Year Ends06-30
Address350 Collins Street,Level 14,Suite 4
CityMelbourne
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3000
Phone61-3-9349-4906
Company Executives
- Name
- Position
- Salary
- Dr. David A. Stamler,M.D.
- Chief Executive Officer
- 1.62M
- Kathryn J.E. Andrews
- Chief Financial Officer
- 359.79K
- Geoffrey Paul Kempler
- Chairman of the Board
- 387.80K
- Lawrence B. Gozlan
- Director
- 107.50K
- Peter A. Marks
- Independent Director
- 70.00K
- Brian Derek Meltzer
- Independent Director
- 70.00K
- Phillip A. Hains
- Company Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg